FIELD: medicine, gastroenterology, pharmacy.
SUBSTANCE: invention describes pharmaceutical compositions and methods used for treatment and prophylaxis of obesity. The composition contains lipase inhibitor being orlistat preferably and the bile acids sequestering agent. Invention provides inhibiting unpleasant gastroenteric symptoms after oral intake of the composition.
EFFECT: valuable medicinal properties of composition.
34 cl, 10 tbl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN | 2003 |
|
RU2297221C2 |
PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND SUCROSE FATTY ACID ESTER | 2002 |
|
RU2271808C2 |
SOLID LIPID COMPOSITIONS | 2000 |
|
RU2248218C2 |
COMPOSITION FOR REDUCING ABSORPTION OF DIETARY FAT | 2011 |
|
RU2566050C2 |
MATERIALS AND METHODS FOR METABOLISM MODULATION | 2005 |
|
RU2387445C2 |
IBAT INHIBITOR FOR TREATING HEPATIC DISORDERS | 2011 |
|
RU2591188C2 |
DISPERSION COMPOSITION CONTAINING LIPASE INHIBITORS | 2000 |
|
RU2239428C2 |
METHODS AND COMPOSITIONS FOR TREATING DISORDERS OF OESOPHAGUS | 2013 |
|
RU2705364C2 |
METHODS AND COMPOSITIONS FOR TREATING OESOPHAGEAL DISORDERS | 2007 |
|
RU2491075C2 |
METHOD FOR PREPARING COMPOSITION | 2001 |
|
RU2244542C2 |
Authors
Dates
2004-12-10—Published
2001-07-19—Filed